Kanabo+ Noidecs T194:C194 Hybrid

Noidecs T194:C194 vapepod is a medical grade inhalation formulation, containing 194mg of THC, 194mg of CBD & 7mg of CBN

Each Inhalation contains:  0.46mg of THC, 0.46mg of CBD and 0.017mg of CBN

• Great taste with no irritation to the throat
• No need for pre-heating. Works from the first inhalation
• Non-GMO
• Gluten-Free
• 100% Vegan
• no additives (no MCT/PG/VG)

The formulations do not include any artificial carrier oils or diluents. All of the company’s products are made with 100% cannabis derivatives and only include Cannabinoids, naturally occurring Terpenes, and Flavonoids; there are absolutely no mineral oils added. Additionally, the formulations go through preclinical and clinical testing at the company’s R&D centre in Israel to ensure safety and efficacy. By offering a high potency product, in principle only a small amount of the formulation is needed to achieve the desired effect

Will also be available to patients registered with Drug Science Project TWENTY21

Noidecs T194:C194 is manufactured in North Macedonia by NYSK Holdings for Lyphe Group in agreement with Kanabo Group and imported to the UK by Astral Health